ASCO 2017- Denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease
Impact of denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease
Author: InternationalMyelomaFoundation
Added: 08/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts